作者：
I Alex,Bowman [1]
;
Alisha,Bent [2]
;
Tri,Le [2]
;
Alana,Christie [3]
;
Zabi,Wardak [4]
;
Yull,Arriaga [5]
;
Kevin,Courtney [5]
;
Hans,Hammers [5]
;
Samuel,Barnett [6]
;
Bruce,Mickey [7]
;
Toral,Patel [6]
;
Tony,Whitworth [6]
;
Strahinja,Stojadinovic [8]
;
Raquibul,Hannan [4]
;
Lucien,Nedzi [8]
;
Robert,Timmerman [4]
;
James,Brugarolas [9]
作者单位：
Kidney Cancer Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX; Division of Hematology and Oncology, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX. Electronic address: isaac.bowman@utsouthwestern.edu.
[1]
Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX.
[2]
Kidney Cancer Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX.
[3]
Kidney Cancer Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX; Department of Radiation Oncology, UT Southwestern Medical Center, Dallas, TX.
[4]
Kidney Cancer Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX; Division of Hematology and Oncology, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX.
[5]
Department of Neurological Surgery, UT Southwestern Medical Center, Dallas, TX.
[6]
Kidney Cancer Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX; Department of Neurological Surgery, UT Southwestern Medical Center, Dallas, TX.
[7]
Department of Radiation Oncology, UT Southwestern Medical Center, Dallas, TX.
[8]
Kidney Cancer Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX; Division of Hematology and Oncology, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX. Electronic address: james.brugarolas@utsouthwestern.edu.
[9]
DOI
10.1016/j.clgc.2018.11.007
PMID
30538068
发布时间
2020-04-01
换一批
换一批
